To figure out whether THAP9-AS1 exerts oncogenic property in ESCC depending on miR-133b, si-THAP9-AS1#2-transfected Eca-109 and KYSE-30 cells were introduced with miR-133b inhibitor. The gene discussed is THAP9; the disease is esophageal squamous cell carcinoma.